코로나19 치료제 개발 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "코로나19 치료제 개발" in Korean language version.

refsWebsite

Global rank Korean rank

14doi.org

2^nd place

3^rd place

11nih.gov

4^th place

3worldcat.org

5^th place

11^th place

3nature.com

234^th place

148^th place

2europa.eu

68^th place

145^th place

2fda.gov

447^th place

433^rd place

1docs.google.com

1,047^th place

1,352^nd place

1milkeninstitute.org

low place

1bioworld.com

low place

1sciencemag.org

857^th place

295^th place

1clinicaltrialsarena.com

low place

1bloomberg.com

99^th place

156^th place

1statnews.com

8,771^st place

7,422^nd place

1scmp.com

362^nd place

557^th place

1thelancet.com

2,393^rd place

1,390^th place

1wellcomeopenresearch.org

low place

1jst.go.jp

1,903^rd place

1,096^th place

1cmaj.ca

low place

8,018^th place

1web.archive.org

1^st place

1sciencealert.com

5,043^rd place

7,438^th place

1bostonglobe.com

553^rd place

3,696^th place

1biocentury.com

low place

1dailyhongkong.com

low place

5,245^th place

1cell.com

2,814^th place

2,861^st place

1cdc.gov

218^th place

52^nd place

biocentury.com

Koch S, Pong W (2020년 3월 13일). “First up for COVID-19: nearly 30 clinical readouts before end of April”. BioCentury Inc. 2020년 4월 1일에 확인함.

bioworld.com

“Biopharma products in development for COVID-19”. BioWorld. 2020년 4월 28일. 2020년 4월 28일에 확인함.

bloomberg.com

“Chinese Vaccine Approved for Human Testing at Virus Epicenter”. 《Bloomberg News》. 2020년 3월 19일. 2020년 3월 21일에 확인함.

bostonglobe.com

Preston E (2020년 3월 19일). “Why will a coronavirus vaccine take so long?”. 《The Boston Globe》. 2020년 3월 21일에 확인함.

cdc.gov

“Information for clinicians on therapeutic options for COVID-19 patients”. US Centers for Disease Control and Prevention. 2020년 3월 21일. 2020년 3월 22일에 확인함.

cell.com

Krishna, Sanjeev; Augustin, Yolanda; Wang, Jigang; Xu, Chengchao; Staines, Henry M.; Platteeuw, Hans; Kamarulzaman, Adeeba; Sall, Amadou; Kremsner, Peter (2021년 1월 19일). “Repurposing Antimalarials to Tackle the COVID-19 Pandemic: (Trends in Parasitology 37, 8–11; 2021)”. 《Trends in Parasitology》 (영어) 0 (0). doi:10.1016/j.pt.2020.12.009. ISSN 1471-4922.

clinicaltrialsarena.com

“China approves first anti-viral drug against coronavirus Covid-19”. Clinical Trials Arena. 2020년 2월 18일. 2020년 3월 21일에 확인함.

cmaj.ca

Cheng MP, Lee TC, Tan DH, Murthy S (2020년 3월 26일). “Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic” (PDF). 《Canadian Medical Association Journal》: cmaj.200438. doi:10.1503/cmaj.200438. ISSN 0820-3946. 2020년 3월 27일에 확인함.

dailyhongkong.com

“[한국과학기술원] 대마초의 CBD와 THC가 SARS-CoV-2 바이러스를 무력화한다”. 2020년 12월 11일. 2022년 8월 31일에 확인함.

docs.google.com

“COVID-19 treatment tracker”. Milken Institute. 2020년 4월 27일. 2020년 4월 27일에 확인함. 요약문.

doi.org

dx.doi.org

Mullard A (April 2020). “Flooded by the torrent: the COVID-19 drug pipeline”. 《Lancet》 395 (10232): 1245–1246. doi:10.1016/S0140-6736(20)30894-1. PMC 7162641. PMID 32305088.
Kupferschmidt K, Cohen J (2020년 3월 22일). “WHO launches global megatrial of the four most promising coronavirus treatments”. 《Science Magazine》. doi:10.1126/science.abb8497. 2020년 3월 27일에 확인함.
Dhama K, Sharun K, Tiwari R, Dadar M, Malik YS, Singh KP, Chaicumpa W (March 2020). “COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics”. 《Human Vaccines & Immunotherapeutics》: 1–7. doi:10.1080/21645515.2020.1735227. PMC 7103671. PMID 32186952.
Zhang L, Liu Y (May 2020). “Potential interventions for novel coronavirus in China: A systematic review”. 《Journal of Medical Virology》 92 (5): 479–490. doi:10.1002/jmv.25707. PMID 32052466.
COVID-19 Clinical Research Coalition (April 2020). “Global coalition to accelerate COVID-19 clinical research in resource-limited settings”. 《Lancet》. doi:10.1016/s0140-6736(20)30798-4. PMID 32247324.
Maguire BJ, Guérin PJ (2020년 4월 2일). “A living systematic review protocol for COVID-19 clinical trial registrations”. 《Wellcome Open Research》 5: 60. doi:10.12688/wellcomeopenres.15821.1. ISSN 2398-502X.
Li G, De Clercq E (March 2020). “Therapeutic options for the 2019 novel coronavirus (2019-nCoV)”. 《Nature Reviews. Drug Discovery》 19 (3): 149–150. doi:10.1038/d41573-020-00016-0. PMID 32127666.
Li G, De Clercq E (March 2020). “Therapeutic options for the 2019 novel coronavirus (2019-nCoV)”. 《Nature Reviews. Drug Discovery》 19 (3): 149–150. doi:10.1038/d41573-020-00016-0. PMID 32127666.
Dong L, Hu S, Gao J (2020년 2월 29일). “Discovering drugs to treat coronavirus disease 2019 (COVID-19)”. 《Drug Discoveries & Therapeutics》 14 (1): 58–60. doi:10.5582/ddt.2020.01012. PMID 32147628.
Harrison C (February 2020). “Coronavirus puts drug repurposing on the fast track”. 《Nature Biotechnology》 38 (4): 379–381. doi:10.1038/d41587-020-00003-1. PMID 32205870.
Cheng MP, Lee TC, Tan DH, Murthy S (2020년 3월 26일). “Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic” (PDF). 《Canadian Medical Association Journal》: cmaj.200438. doi:10.1503/cmaj.200438. ISSN 0820-3946. 2020년 3월 27일에 확인함.
Thanh Le T, Andreadakis Z, Kumar A, Gómez Román R, Tollefsen S, Saville M, Mayhew S (April 2020). “The COVID-19 vaccine development landscape”. 《Nature Reviews. Drug Discovery》. doi:10.1038/d41573-020-00073-5. PMID 32273591.
Kruse RL (2020년 1월 31일). “Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China”. 《F1000Research》 9: 72. doi:10.12688/f1000research.22211.1. PMC 7029759. PMID 32117569.
Krishna, Sanjeev; Augustin, Yolanda; Wang, Jigang; Xu, Chengchao; Staines, Henry M.; Platteeuw, Hans; Kamarulzaman, Adeeba; Sall, Amadou; Kremsner, Peter (2021년 1월 19일). “Repurposing Antimalarials to Tackle the COVID-19 Pandemic: (Trends in Parasitology 37, 8–11; 2021)”. 《Trends in Parasitology》 (영어) 0 (0). doi:10.1016/j.pt.2020.12.009. ISSN 1471-4922.

europa.eu

ema.europa.eu

“First regulatory workshop on COVID-19 facilitates global collaboration on vaccine development”. European Medicines Agency. 2020년 3월 18일. 2020년 3월 21일에 확인함.
“Call to pool research resources into large multi-centre, multi-arm clinical trials to generate sound evidence on COVID-19 treatments”. European Medicines Agency. 2020년 3월 19일. 2020년 3월 21일에 확인함.

fda.gov

“Coronavirus (COVID-19) Update: FDA Continues to Facilitate Development of Treatments”. US Food and Drug Administration. 2020년 3월 19일. 2020년 3월 21일에 확인함.
“The Drug Development Process”. US Food and Drug Administration. 2018년 1월 4일. 2020년 3월 21일에 확인함.

jst.go.jp

jstage.jst.go.jp

Dong L, Hu S, Gao J (2020년 2월 29일). “Discovering drugs to treat coronavirus disease 2019 (COVID-19)”. 《Drug Discoveries & Therapeutics》 14 (1): 58–60. doi:10.5582/ddt.2020.01012. PMID 32147628.

milkeninstitute.org

“COVID-19 treatment tracker”. Milken Institute. 2020년 4월 27일. 2020년 4월 27일에 확인함. 요약문.

nature.com

Harrison C (February 2020). “Coronavirus puts drug repurposing on the fast track”. 《Nature Biotechnology》 38 (4): 379–381. doi:10.1038/d41587-020-00003-1. PMID 32205870.
Thanh Le T, Andreadakis Z, Kumar A, Gómez Román R, Tollefsen S, Saville M, Mayhew S (April 2020). “The COVID-19 vaccine development landscape”. 《Nature Reviews. Drug Discovery》. doi:10.1038/d41573-020-00073-5. PMID 32273591.

media.nature.com

Li G, De Clercq E (March 2020). “Therapeutic options for the 2019 novel coronavirus (2019-nCoV)”. 《Nature Reviews. Drug Discovery》 19 (3): 149–150. doi:10.1038/d41573-020-00016-0. PMID 32127666.

nih.gov

ncbi.nlm.nih.gov

Mullard A (April 2020). “Flooded by the torrent: the COVID-19 drug pipeline”. 《Lancet》 395 (10232): 1245–1246. doi:10.1016/S0140-6736(20)30894-1. PMC 7162641. PMID 32305088.
Dhama K, Sharun K, Tiwari R, Dadar M, Malik YS, Singh KP, Chaicumpa W (March 2020). “COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics”. 《Human Vaccines & Immunotherapeutics》: 1–7. doi:10.1080/21645515.2020.1735227. PMC 7103671. PMID 32186952.
Zhang L, Liu Y (May 2020). “Potential interventions for novel coronavirus in China: A systematic review”. 《Journal of Medical Virology》 92 (5): 479–490. doi:10.1002/jmv.25707. PMID 32052466.
COVID-19 Clinical Research Coalition (April 2020). “Global coalition to accelerate COVID-19 clinical research in resource-limited settings”. 《Lancet》. doi:10.1016/s0140-6736(20)30798-4. PMID 32247324.
Li G, De Clercq E (March 2020). “Therapeutic options for the 2019 novel coronavirus (2019-nCoV)”. 《Nature Reviews. Drug Discovery》 19 (3): 149–150. doi:10.1038/d41573-020-00016-0. PMID 32127666.
Li G, De Clercq E (March 2020). “Therapeutic options for the 2019 novel coronavirus (2019-nCoV)”. 《Nature Reviews. Drug Discovery》 19 (3): 149–150. doi:10.1038/d41573-020-00016-0. PMID 32127666.
Dong L, Hu S, Gao J (2020년 2월 29일). “Discovering drugs to treat coronavirus disease 2019 (COVID-19)”. 《Drug Discoveries & Therapeutics》 14 (1): 58–60. doi:10.5582/ddt.2020.01012. PMID 32147628.
Harrison C (February 2020). “Coronavirus puts drug repurposing on the fast track”. 《Nature Biotechnology》 38 (4): 379–381. doi:10.1038/d41587-020-00003-1. PMID 32205870.
Thanh Le T, Andreadakis Z, Kumar A, Gómez Román R, Tollefsen S, Saville M, Mayhew S (April 2020). “The COVID-19 vaccine development landscape”. 《Nature Reviews. Drug Discovery》. doi:10.1038/d41573-020-00073-5. PMID 32273591.
Kruse RL (2020년 1월 31일). “Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China”. 《F1000Research》 9: 72. doi:10.12688/f1000research.22211.1. PMC 7029759. PMID 32117569.

ncats.nih.gov

“Repurposing drugs”. National Center for Advancing Translational Sciences (NCATS). 2017년 11월 7일. 2020년 3월 26일에 확인함.

sciencealert.com

Grenfell R, Drew T (2020년 2월 17일). “Here's Why It's Taking So Long to Develop a Vaccine for the New Coronavirus”. 《ScienceAlert》. 2020년 2월 28일에 원본 문서에서 보존된 문서. 2020년 2월 26일에 확인함.

sciencemag.org

Kupferschmidt K, Cohen J (2020년 3월 22일). “WHO launches global megatrial of the four most promising coronavirus treatments”. 《Science Magazine》. doi:10.1126/science.abb8497. 2020년 3월 27일에 확인함.

scmp.com

Chan M (2020년 3월 19일). “Chinese military scientists ordered to win global race to develop coronavirus vaccine”. 《South China Morning Post》. 2020년 3월 22일에 확인함.

statnews.com

Fox M (2020년 3월 19일). “Drug makers are racing to develop immune therapies for Covid-19. Will they be ready in time?”. Stat. 2020년 3월 21일에 확인함.

thelancet.com

COVID-19 Clinical Research Coalition (April 2020). “Global coalition to accelerate COVID-19 clinical research in resource-limited settings”. 《Lancet》. doi:10.1016/s0140-6736(20)30798-4. PMID 32247324.

web.archive.org

Grenfell R, Drew T (2020년 2월 17일). “Here's Why It's Taking So Long to Develop a Vaccine for the New Coronavirus”. 《ScienceAlert》. 2020년 2월 28일에 원본 문서에서 보존된 문서. 2020년 2월 26일에 확인함.

wellcomeopenresearch.org

Maguire BJ, Guérin PJ (2020년 4월 2일). “A living systematic review protocol for COVID-19 clinical trial registrations”. 《Wellcome Open Research》 5: 60. doi:10.12688/wellcomeopenres.15821.1. ISSN 2398-502X.

worldcat.org

Maguire BJ, Guérin PJ (2020년 4월 2일). “A living systematic review protocol for COVID-19 clinical trial registrations”. 《Wellcome Open Research》 5: 60. doi:10.12688/wellcomeopenres.15821.1. ISSN 2398-502X.
Cheng MP, Lee TC, Tan DH, Murthy S (2020년 3월 26일). “Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic” (PDF). 《Canadian Medical Association Journal》: cmaj.200438. doi:10.1503/cmaj.200438. ISSN 0820-3946. 2020년 3월 27일에 확인함.
Krishna, Sanjeev; Augustin, Yolanda; Wang, Jigang; Xu, Chengchao; Staines, Henry M.; Platteeuw, Hans; Kamarulzaman, Adeeba; Sall, Amadou; Kremsner, Peter (2021년 1월 19일). “Repurposing Antimalarials to Tackle the COVID-19 Pandemic: (Trends in Parasitology 37, 8–11; 2021)”. 《Trends in Parasitology》 (영어) 0 (0). doi:10.1016/j.pt.2020.12.009. ISSN 1471-4922.